Management of hypoparathyroidism

Summary statement and guidelines

Maria Luisa Brandi, John P. Bilezikian, Dolores Shoback, Roger Bouillon, Bart Clarke, Rajesh V. Thakker, Aliya A. Khan, John T. Potts

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder. Participants: Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7-9, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement. Evidence: Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Consensus Process: This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism. Conclusions: This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.

Original languageEnglish (US)
Pages (from-to)2273-2283
Number of pages11
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Hypoparathyroidism
Guidelines
Epidemiology
Education
Hypocalcemia
Manuscripts
Italy
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Brandi, M. L., Bilezikian, J. P., Shoback, D., Bouillon, R., Clarke, B., Thakker, R. V., ... Potts, J. T. (2016). Management of hypoparathyroidism: Summary statement and guidelines. Journal of Clinical Endocrinology and Metabolism, 101(6), 2273-2283. https://doi.org/10.1210/jc.2015-3907

Management of hypoparathyroidism : Summary statement and guidelines. / Brandi, Maria Luisa; Bilezikian, John P.; Shoback, Dolores; Bouillon, Roger; Clarke, Bart; Thakker, Rajesh V.; Khan, Aliya A.; Potts, John T.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 6, 01.06.2016, p. 2273-2283.

Research output: Contribution to journalArticle

Brandi, ML, Bilezikian, JP, Shoback, D, Bouillon, R, Clarke, B, Thakker, RV, Khan, AA & Potts, JT 2016, 'Management of hypoparathyroidism: Summary statement and guidelines', Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 6, pp. 2273-2283. https://doi.org/10.1210/jc.2015-3907
Brandi, Maria Luisa ; Bilezikian, John P. ; Shoback, Dolores ; Bouillon, Roger ; Clarke, Bart ; Thakker, Rajesh V. ; Khan, Aliya A. ; Potts, John T. / Management of hypoparathyroidism : Summary statement and guidelines. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 6. pp. 2273-2283.
@article{00d7ee5dbe65494582a01c16599062a8,
title = "Management of hypoparathyroidism: Summary statement and guidelines",
abstract = "Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder. Participants: Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7-9, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement. Evidence: Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Consensus Process: This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism. Conclusions: This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.",
author = "Brandi, {Maria Luisa} and Bilezikian, {John P.} and Dolores Shoback and Roger Bouillon and Bart Clarke and Thakker, {Rajesh V.} and Khan, {Aliya A.} and Potts, {John T.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1210/jc.2015-3907",
language = "English (US)",
volume = "101",
pages = "2273--2283",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Management of hypoparathyroidism

T2 - Summary statement and guidelines

AU - Brandi, Maria Luisa

AU - Bilezikian, John P.

AU - Shoback, Dolores

AU - Bouillon, Roger

AU - Clarke, Bart

AU - Thakker, Rajesh V.

AU - Khan, Aliya A.

AU - Potts, John T.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder. Participants: Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7-9, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement. Evidence: Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Consensus Process: This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism. Conclusions: This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.

AB - Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder. Participants: Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7-9, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement. Evidence: Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Consensus Process: This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism. Conclusions: This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.

UR - http://www.scopus.com/inward/record.url?scp=84973562918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973562918&partnerID=8YFLogxK

U2 - 10.1210/jc.2015-3907

DO - 10.1210/jc.2015-3907

M3 - Article

VL - 101

SP - 2273

EP - 2283

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -